IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,795,341 | -63.0% | 113,128 | -56.1% | 0.07% | -62.3% |
| Q2 2023 | $4,857,478 | +5711.4% | 257,418 | +1082.6% | 0.18% | +6000.0% |
| Q1 2023 | $83,585 | +22.0% | 21,767 | +57.6% | 0.00% | -25.0% |
| Q4 2022 | $68,517 | -93.5% | 13,814 | -93.7% | 0.00% | -90.2% |
| Q3 2022 | $1,048,000 | +638.0% | 219,140 | +593.0% | 0.04% | +583.3% |
| Q2 2022 | $142,000 | -27.6% | 31,621 | -23.1% | 0.01% | -25.0% |
| Q1 2022 | $196,000 | -64.6% | 41,146 | -44.8% | 0.01% | -77.1% |
| Q4 2021 | $553,000 | +870.2% | 74,500 | +641.4% | 0.04% | +775.0% |
| Q3 2021 | $57,000 | -83.2% | 10,048 | -76.0% | 0.00% | -87.5% |
| Q1 2021 | $339,000 | – | 41,890 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |